Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1217031.RAYgLT_HxYSKeuB7IM69gLPPW7CuG67ZSu3M4MQlN0kLQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1217031.RAYgLT_HxYSKeuB7IM69gLPPW7CuG67ZSu3M4MQlN0kLQ130_assertion type Assertion NP1217031.RAYgLT_HxYSKeuB7IM69gLPPW7CuG67ZSu3M4MQlN0kLQ130_head.
- NP1217031.RAYgLT_HxYSKeuB7IM69gLPPW7CuG67ZSu3M4MQlN0kLQ130_assertion description "[Preclinical studies have suggested that the mTOR pathway may play a role in the resistance to hormone therapy, trastuzumab and chemotherapy for breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1217031.RAYgLT_HxYSKeuB7IM69gLPPW7CuG67ZSu3M4MQlN0kLQ130_provenance.
- NP1217031.RAYgLT_HxYSKeuB7IM69gLPPW7CuG67ZSu3M4MQlN0kLQ130_assertion evidence source_evidence_literature NP1217031.RAYgLT_HxYSKeuB7IM69gLPPW7CuG67ZSu3M4MQlN0kLQ130_provenance.
- NP1217031.RAYgLT_HxYSKeuB7IM69gLPPW7CuG67ZSu3M4MQlN0kLQ130_assertion SIO_000772 25189767 NP1217031.RAYgLT_HxYSKeuB7IM69gLPPW7CuG67ZSu3M4MQlN0kLQ130_provenance.
- NP1217031.RAYgLT_HxYSKeuB7IM69gLPPW7CuG67ZSu3M4MQlN0kLQ130_assertion wasDerivedFrom befree-2016 NP1217031.RAYgLT_HxYSKeuB7IM69gLPPW7CuG67ZSu3M4MQlN0kLQ130_provenance.
- NP1217031.RAYgLT_HxYSKeuB7IM69gLPPW7CuG67ZSu3M4MQlN0kLQ130_assertion wasGeneratedBy ECO_0000203 NP1217031.RAYgLT_HxYSKeuB7IM69gLPPW7CuG67ZSu3M4MQlN0kLQ130_provenance.